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ABSTRACT Exposure of the genital mucosa to a genetically diverse viral swarm
from the donor HIV-1 can result in breakthrough and systemic infection by a single
transmitted/founder (TF) virus in the recipient. The highly diverse HIV-1 envelope
(Env) in this inoculating viral swarm may have a critical role in transmission and sub-
sequent immune response. Thus, chronic (Envchronic) and acute (Envacute) Env chimeric
HIV-1 were tested using multivirus competition assays in human mucosal penile and
cervical tissues. Viral competition analysis revealed that Envchronic viruses resided and
replicated mainly in the tissue, while Envacute viruses penetrated the human tissue
and established infection of CD41 T cells more efficiently. Analysis of the replication
fitness, as tested in peripheral blood mononuclear cells (PBMCs), showed similar rep-
lication fitness of Envacute and Envchronic viruses, which did not correlate with trans-
mission fitness in penile tissue. Further, we observed that chimeric Env viruses with
higher replication in genital mucosal tissue (chronic Env viruses) had higher binding
affinity to C-type lectins. Data presented herein suggest that the inoculating HIV-1
may be sequestered in the genital mucosal tissue (represented by chronic Env HIV-1)
but that a single HIV-1 clone (e.g., acute Env HIV-1) can escape this trapped replica-
tion for systemic infection.
IMPORTANCE During heterosexual HIV-1 transmission, a genetic bottleneck occurs in
the newly infected individual as the virus passes from the mucosa, leading to sys-
temic infection with a single transmitted HIV-1 clone in the recipient. This bottleneck
in the recipient has just been described (K. Klein et al., PLoS Pathog 14:e1006754,
https://doi.org/10.1371/journal.ppat.1006754), and the mechanisms involved in this
selection process have not been elucidated. However, understanding mucosal restric-
tion is of the utmost importance for understanding dynamics of infections and for
designing focused vaccines. Using our human penile and cervical mucosal tissue mod-
els for mixed HIV infections, we provide evidence that HIV-1 from acute/early infection,
compared to that from chronic infection, can more efficiently traverse the mucosal ep-
ithelium and be transmitted to T cells, suggesting higher transmission fitness. This
study focused on the role of the HIV-1 envelope in transmission and provides strong
evidence that HIV transmission may involve breaking the mucosal lectin trap.
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In the global spread of human immunodeficiency virus type 1 (HIV-1), the virus ismost commonly transmitted during sexual intercourse. For this transmission event,
the inoculating virus in vaginal fluids or semen must penetrate physical barriers, such
as the mucus and epithelium of the genital mucosal tissue, to establish a propagating
infection in susceptible target cells located in the underlying stroma. Regardless of the
genital tissue, the risk of HIV-1 transmission per coital act is very low for receptive
(0.08%) and insertive (0.04%) penile-vaginal intercourse (1), which is one factor associ-
ated with the higher and increasing HIV prevalence in women (2).
Over the years, multiple studies have indicated that a primary HIV-1 infection is initi-
ated by one clone or a small number of transmitted/founder (TF) HIV-1 clones despite
the presence of a diverse HIV-1 population in the donor (3, 4). Previous studies have
examined the genetic bottlenecks from donor to recipient by describing the HIV in the
blood of donors and recipients following transmission. However, there is considerable
complexity in these transmission bottlenecks, in that the virus migrates and compart-
mentalizes in different tissues within the donor. For example, in a female-to-male HIV-
1 transmission event, the virus within the female genital tract (FGT) could have been
present since the time of acute infection. It is therefore possible that the virus could
have evolved in the FGT or likely entered the FGT via the blood. Thus, the HIV-1 that is
transmitted from the FGT to the penile tissue in female-to-male transmission may
reflect what is transmitted from the vaginal mucosa rather than directly from the
blood, in the absence of injury. The virus that infects the penile tissue may have origi-
nated from infection of the foreskin, urethra, or the glans tissue and then may pass
into the blood, disseminate into different tissues, and migrate into the testes through
a barrier similar to the blood-brain barrier. Thus, predicting the efficiency of transmis-
sion from donor blood to recipient blood may not relate directly to the actual transmis-
sion event, i.e., the virus population moving through various genetic bottlenecks and
barriers (5). Different barriers during this transmission process may place the inoculat-
ing HIV-1 population under different, possibly distinct selective pressures leading to
systemic infection by one predominant HIV-1 clone. We recently provided in vivo evi-
dence that an HIV-1 population and not a single clone infects the vaginal tract during
male-to-female transmission and that a possible genetic bottleneck from the vaginal
tract to the blood results in systemic infection by a single HIV-1 clone (6). However, it is
still not fully understood if this transmission bottleneck is a stochastic event or involves
selection for a specific viral function/activity which may be mapped to viral protein
structure(s), linear sequence(s), or posttranslational modifications. It is also unclear
how genital microbiome, innate immune status, and other host factors could influence
this HIV clonal selection during transmission (7–10). For the development of a success-
ful preventive HIV-1 vaccine, it will be critical to obtain in-depth knowledge of the gen-
otypic and phenotypic properties of the transmitted compared to the nontransmitted
HIV-1 clones.
When comparing blood-derived HIV-1 from chronic and acute infections, we and
others observed no differences in receptor usage, sensitivity to entry inhibitors, and
cell tropism (11, 12). Interestingly, the chronic HIV-1, tested as a virus population
and not a single clone, appears to have higher replicative fitness and greater host cell
entry efficiency than the acute HIV-1, typically a single clone (12, 13). However, many
studies have focused on identifying signature sequences of the TF clones, making it
distinct in the inoculating HIV-1 swarm from the human donor (14–16). For example,
alpha interferon (IFN-a) resistance encoded by the gag gene may be a distinct feature
of TF HIV-1, but this has been the subject of debate (9, 11, 17). Typically, TF viruses
have been shown to utilize CD4 and CCR5 for cell entry (3). Additionally, fewer poten-
tial N-linked glycosylation sites (PNGS) and shorter variable loops have been linked to
the TF phenotype (18). One study showed that infectious molecular clones of TF were
more infectious and expressed more envelope on the surface than HIV-1 molecular
clones derived from chronic disease (17). However, there is still considerable debate
about Env properties of TF HIV-1. A reduced glycan shield on TF HIV-1 (9, 19, 20) was
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thought to improve replicative fitness and/or host cell entry; i.e., it may be a favorable
trait for transmission. However, TF clones with fewer N-linked glycan sites had no clear
advantage in terms of replicative rate, receptor/coreceptor binding, or entry efficiency
over HIV-1 found during chronic disease (11, 12, 21). The factors governing infection
by HIV-1 harboring Env with fewer N-linked sites during acute infection remain poorly
understood. Clearly, the emergence of HIV-1-specific antibodies following early infec-
tion selects for new N-linked sites, especially in the Env hypervariable loops, which cor-
responds to viral escape from this immune pressure (22). Compared to chronic HIV-1,
TF viruses may bind more efficiently to dendritic cells (DCs) for transmission in trans to
CD41 T cells (17, 23), but other studies suggest the opposite (12, 14).
The impact of the Env on the replication efficiency of HIV-1 isolates in primary T
cells, macrophages, and DCs has been well described (12, 21), but the role of Env in
transmission is poorly understood. Thus, the HIV-1 env genes from individuals during
acute/early and chronic disease were analyzed in the context of the same NL4-3 HIV-1
backbone. Acute (Envacute) and chronic (Envchronic) Env chimeric viruses were then
tested in multivirus competition assays in human ex vivo penile and cervical tissue to
determine if specific Env properties influence the transmission fitness. Differential
transmission fitness was compared to replicative fitness in primary CD41 T cells and C-
type lectin binding affinity. C-type lectin receptors are a family of transmembrane and
soluble receptors containing carbohydrate recognition domains (24), expressed mostly
by myeloid cells. They play critical roles in both innate and adaptive immunity and
have been shown to have important protective functioning at mucosal barriers while
also facilitating binding and capture of HIV-1 by antigen-presenting cells (APCs) (25).
Here, transmission fitness experiments were carried out in penile and cervical tissue
following incubation with mannan, a high-mannose polysaccharide, to saturate C-type
lectins, found throughout the mucosal tissues by immunofluorescent staining. Based
on the studies described herein, increased transmission fitness of HIV-1 may relate to
“breaking” the C-type lectin trap in mucosal tissue.
RESULTS
Multivirus infection in human explant tissue as a model for mucosal HIV-1
transmission fitness. To approximate transmission fitness, we employed an ex vivo tis-
sue model to test the transmissibility of both acute and chronic Env chimeric viruses.
Eleven Envacute and three Envchronic viruses that were previously constructed and charac-
terized (12, 26) were used in this study. Phylogenetic analysis and characteristics of all
Envacute and Envchronic viruses employed in this study are presented in the phylogenetic
tree in Fig. 1c. Titers of all viruses were determined on phytohemagglutinin (PHA)/
interleukin 2 (IL-2)-treated peripheral blood mononuclear cells (PBMCs) using the
standard TCID50 (50% tissue culture infective dose) method. In the example illustrated
in Fig. 1, human penile glans tissue was exposed to a mix of seven Envacute HIV-1 (B1,
B2, B3, B4, B17, B19, and B20), each at 150 infectious units (IU), for 3 h and then washed
and cultured overnight. At 24 h, migratory cells (MC) were collected and cocultured
with PM1 clonal CD41 T cells. Following 10 days in culture, tissue and MC1PM1 cocul-
tures from the mixed infections were analyzed for relative virus production.
As detailed in Materials and Methods, barcoded Env C2-V3 amplicons were
sequenced from tissue and MC1PM1 cocultures from each mixed-virus competition.
SeekDeep (27) was then used to count sequence reads aligning to each virus added to
the competition (Fig. 1a). The relative percentages of the B1, B2, B3, B4, B17, B19, and
B20 viruses obtained are shown in Fig. 1b. Additionally, C2-V3 sequences from the
same barcoded product were aligned to Envacute, and the maximum-likelihood tree in
Fig. 1c shows one representative phylogenetic tree of the C2-V3 sequences amplified
from the tissue at 10 days after multivirus infection. As described above, the Env con-
sensus sequence ID labels of viruses used in this study is shown in Fig. 1c (in black
text), while the virus ID labels specific for this mixed-virus competition are shown in
colored text (Fig. 1c). The maximum-likelihood tree (Fig. 1c) and the SeekDeep analyses
(Fig. 1b) were congruent and show that Envacute B19 (nearly 80%) followed by B4
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FIG 1 Schematic of transmission fitness assay and analyses of multivirus infections. (a) Human explant tissue was exposed to a mixture of Envacute and
Envchronic viruses for 3 h, washed, and cultured overnight. Cells migrating out of the tissue were collected and cocultured with PM1 CD4
1 T cells. After
(Continued on next page)
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dominated the multivirus competition in tissue, whereas B1 was found at a low per-
centage. The ,1% not mapping to one of the seven HIV-1 isolates were identified as
recombinants of B4 and B19 (Fig. 1c).
Despite the high level of B19 replication in the tissue, this virus was not identified in
the MC1PM1 cocultures, suggesting that this virus was not carried by the MC out of
the tissue. In contrast, the B4 virus was efficiently carried through the tissue to infect
and propagate in CD41 T cells (Fig. 1b). In the subsequent multivirus competitions, we
found low levels of stochastic infection by all Envacute and Envchronic HIV-1 of the tissue
and transmission to T cells. However, in general, Envacute viruses were more readily
transmitted through the penile and cervical tissue to infect T cells, whereas other HIV-1
Env strains (i.e., Envchronic) propagated primarily in the tissue.
To phenotypically characterize the emigrating DCs, tissue blocks were cultured
overnight and MC were collected and stained with a multicolor antibody cocktail for
flow cytometry. Analysis of the phenotype present within the mDC population derived
from penile (n=5) and cervical (n=3) tissue revealed that 80% and 28% are CD1c posi-
tive, 20% and 12% are CD207 (langerin) positive, and 3.95% and 7.69% are CD209 (DC-
SIGN) positive (Fig. 2), which is in accordance with previous findings (28–30).
FIG 2 Characterization of the migratory cell phenotype in penile and cervical tissue. The percentages
of CD1c-, CD83-, CD207-, and CD209-positive cells of all viable mDCs isolated from penile (n=5) and
cervical (n= 3) tissue were assessed by a multicolor flow panel on an LSRIIFortessa flow cytometer.
Box-and-whisker plots show median, minimum/maximum, and 25th/75th percentiles of the
percentage of viable cells stratified by CD1c, CD83, CD207, and CD209 expression. Each symbol
represents an individual penile or cervical tissue donor.
FIG 1 Legend (Continued)
10 days, both tissue and MC1PM1 cocultures were lysed, and DNA was extracted for PCR amplification of the C2-V3 envelope region. After ligation of
barcoded oligonucleotides, purification, and quantification, equivalent amounts of products were subject to NGS. Data analysis was performed using
SeekDeep, a custom pipeline sorting sequences based on barcodes and aligning sequences within barcode bins. (b) Results of multivirus infections are
presented as percent sequence reads of each virus detected in the assay in tissue or MC1PM1 cocultures. Gray bars indicate the percentage of sequences
from that barcoded PCR product (representing this multivirus competition) mapped to one of the seven viruses in the competitions. It is important to note
that these analyses involve counting HIV isolates based on phylogenetic clustering, where low-frequency mutations do not impact the analyses. This was
verified as shown in panel c. The relative amount of each virus in the competition was determined using maximum-likelihood trees of the HIV-1 C2-V3 env
DNA amplified from tissue or MC1PM1 cocultures. Env sequence in the maximum likelihood tree of panel c in the bold and larger colored text and the
black text represent the C3-V3 gp120 sequences of all the chimeric Env HIV-1 strains that were employed in the various multi-virus competitions used in
this study (see below). For the representative multi-virus competition results shown in this figure, the Env chimeric viruses used in this competition are the
branch points on the tree labeled with the colored text. The small text labels (text not important) show the individual branches/sequences defined as NGS
reads "counted" from the multivirus competitions by SeekDeep. The reference sequences for the viruses in this competition are shown in italic, bold, large
text, namely B1-1054.TC4.1499 (red), B2-6244 (yellow), B3-PRB926 (dark blue), B4-WEAUd15.410.5017 (light blue), B17-REJO.D12.1972 (purple), BB19-
700010040.C9.4520 (brown), and B20-63358.p3.4013 (orange on the tree but pink for rest of figure). A few recombinant B19/B4 sequences were identified
in this competition and were identified as a mixed brown/light blue text label. Of all HIV sequences in the maximum-likelihood tree (c) from the matched-
input viruses (B1, B2, B3, B4, B19, and B20), only B1, B4, and B19 replicated in the tissue (see replicate 1 of the tissue in panel b). Less than 1%, or 4
sequences, were recombinants of B4 and B19 with different breakpoints.
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Higher transmission fitness of acute over chronic Env chimeric viruses in the
human penile and cervical tissue transmission model. Due to limited availability of
cervical tissue, multivirus competitions were predominantly performed in human pen-
ile tissue as a model for transmission fitness. Tissue was exposed to a mix of three or
four Envacute viruses (B1, B2, B3, B4, B7, B8, B9, B14, B17, B19, and B20) plus three
Envchronic viruses (I10, K44, and Q0), each virus at 150 IU. Eight different mixtures of
Envacute viruses ensured that all 11 Envacute viruses competed against each other and
with the same three Envchronic viruses (Fig. 3). The relative production of each virus in
tissue and MC1PM1 multivirus competitions was analyzed as described in Fig. 1.
Relative replication of the total Envacute versus Envchronic viruses was compared in tissue
and MC1PM1 cocultures (Fig. 3a and b). With the exception of one mixed-virus com-
petition (B9, B14, B17, B19, I10, K44, and Q0), Envchronic outreplicated Envacute in penile
tissue (Fig. 3a), to a significant degree in 4 mixed-virus competitions. Even though the
chronic virus represents only 43 to 50% of the inoculating virus, chronic virus repre-
sented 80% of the virus replicating in the tissue (7 of 8 competitions) (Fig. 3a and c).
In complete contrast to the preferential Envchronic replication in the tissue, Envacute
significantly outreplicated Envchronic HIV in the MC1PM1 cocultures in 6 of the 8 multi-
virus infections (Fig. 3b and c). For this to occur, Envacute HIV-1 must have been prefer-
entially carried out of the tissue by MC and then transferred to PM1 cells. Combined,
Envacute HIV-1 contributed to over 80% of the virus replication in all but two multivirus
infections (Fig. 3b and c). In these two multivirus infections (B2, B7, B17, I10, K44, and
Q0 and B3, B8, B14, B20, I10, K44, and Q0), Envchronic not only was transmitted to the T
cells but also replicated within the tissue (Fig. 3a and b).
Analyses of individual virus replication in the competitions (Fig. 4), differential trans-
mission fitness of acute HIV-1 was evident in 8 different multivirus infections in penile
tissue. Of the 11 Envacute viruses, B4, B7, and B9 consistently showed the highest trans-
mission fitness when combined with the same three Envchronic viruses but different
combinations of the other 8 Envacute HIV-1 (Fig. 4f, g, h, i, j, o, and p). When B4, B7, and
B9 (Fig. 4b and g) or B7 and B9 (Fig. 4l and o), were in competition together, the acute
B9 virus was preferentially transmitted through the tissue by MC to replicate in PM1
cells. In the two competitions where Envchronic was transmitted more efficiently than
Envacute (Fig. 4e, j, k, and l), the highly “transmissible” B4 and B9 were not included in
the multivirus competitions.
Comparing HIV-1 transmission fitness in an endocervical versus penile glans
tissue model. Penile and endocervical tissues were exposed to I10, K44, QO, B3, B4,
B19, and B20 using the experimental procedures described above (Fig. 1). The relative
replication in the penile and cervical tissue was similar in that Envacute was again prefer-
entially transmitted through the tissue to infect T cells via MC (Fig. 4q and r). We fre-
quently observed stochastic replication of Envacute in the tissue along with Envchronic in
these multivirus competitions. For example, high-level B4 replication was observed in
multivirus competitions in the penile tissue (Fig. 4a and m) as well as in the endocervi-
cal tissue (Fig. 4q). In contrast, when Envacute viruses with high transmission fitness
were present in the multivirus competitions, Envchronic HIV-1 were not transmitted and
were almost completely absent in the MC1PM1 cocultures (Fig. 4f, g, h, i, o, p, and r).
The patterns of relative HIV-1 replication were similar in experiments using penile and
cervical tissue, i.e., Envchronic viruses had sequestered replication in the tissue, while
Envacute viruses are preferentially taken up by MC and transferred to T cells (Fig. 3d).
Replication of Envacute B4 in the cervical tissue from one of the mixed-virus competi-
tions in one of two donors highlights the stochastic replication of HIV-1 in tissue with
some mixed-virus competitions. Nonetheless, Envacute HIV-1 viruses were still preferen-
tially transmitted by the migratory cells from the cervical tissue to free CD41 T cells
(Fig. 3d).
Transmission fitness does not correlate with replicative fitness in peripheral
blood mononuclear cells. The average relative fitness of each virus in the tissue or
transmitted by MC to the T cells is shown in Fig. 5a and b (respectively) from the total
of all 8 multivirus competitions performed in penile tissues from two donors. Again,
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FIG 3 Higher transmission fitness of Envacute versus Envchronic viruses in multivirus competition assays in human tissue. (a) Penile tissues were dissected into
3-mm3 explants and exposed to eight different mixtures of a panel of Envacute viruses and the same three Envchronic viruses. (b) Following overnight culture,
migrating cells from the tissue were collected and cocultured with PM1 T cells (MC1PM1). After 10 days in culture, DNA from tissue and MC1PM1 cells
was isolated, PCR amplified, and analyzed by NGS. The cumulative percent replication in penile tissue (a) and in MC1PM1 cocultures (b) of Envchronic and
Envacute viruses for tissue A and tissue B in each of the eight multivirus panels is shown. (c) The combined average replication of all Envchronic and all
Envacute viruses of the eight virus competitions in penile tissues and Envchronic (green bars) and Envacute (red bars) viruses in MC1PM1 cocultures was
determined. Each competition was done in triplicates in tissues from two donors. (d) Average replication of Envchronic (bars with green outlines) and Envacute
(bars with red outlines) viruses of one competition set in cervical tissue and the corresponding MC1PM1 cocultures were evaluated by NGS. Statistical
significance was determined using the Holm-Sidak method (a and b) (*, P, 0.05) and a two-tailed Mann-Whitney test (c and d) (***, P, 0.001; ****,
P, 0.0001).
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B4, B7, and B9 had the highest transmission fitness using this penile explant model.
We had previously reported on the replicative fitness of each acute virus in competi-
tion against the same three Envchronic viruses (I10, K44, and Q0) in PHA- and IL-2-treated
PBMCs (21, 31) (Fig. 5c). Dual-virus competitions in PBMCs showed that all Envacute
viruses could replicate with lower or higher fitness than the competing Envchronic
viruses (Fig. 5c). Replication of B1, B2, B3, B17, and B20 was low or undetected in both
tissue and MC1PM1 cocultures in the penile tissue model (Fig. 5a and b), whereas the
same stocks replicated efficiently in PBMCs (Fig. 5c). In Fig. 5d, the average replicative
fitness of the Envacute viruses in PBMCs (from Fig. 5c) is plotted against the replication
of these viruses in tissue and MC1PM1 cocultures derived from the multivirus compet-
itions in penile tissue (from Fig. 5a and b). Previous studies revealed a direct correlation
between the replicative fitness of the infecting HIV-1 (as determined in PBMCs and pri-
mary T cells) and subsequent disease progression (26, 31–33). We observed no
FIG 4 Multivirus competition assays to assess the transmission fitness across penile and cervical tissue. Penile and cervical explants were exposed to
mixtures of three Envchronic viruses (I10, K44, and Q0) and three to five Envacute viruses (B1, B2, B3, B4, B7, B8, B9, B14, B17, B19, and B20) for 3 h. After
overnight culture, migrating cells from the tissue were collected and cocultured with CD41 PM1 T cells (MC1PM1). Following 10 days in culture, both
tissue and MC1PM1 cocultures were lysed and PCR amplified, and replication of viruses was analyzed by NGS. (a to p) Percent replication of eight
different mixtures of Envchronic and Envacute viruses in tissues from donor A and donor B and Envchronic and Envacute viruses in the corresponding MC1PM1
cocultures. Each graph shows the percentage of sequence reads for donor A and donor B from the NGS analysis mapped to the viruses present in the
competitions. (q and r) Side-by-side comparison of Envchronic and Envacute virus replication in penile tissue and Envchronic and Envacute virus replication in
cervical tissue (q) and comparison of transmission fitness of Envchronic and Envacute viruses in MC1PM1 derived from penile tissue with transmission fitness
of Envchronic and Envacute viruses in MC1PM1 from cervical tissue (r) of one competition set (I10, K44, and Q0 and B1, B3, B4, B19, and B20).
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correlation between replicative fitness of Envacute HIV-1 with the replicative fitness in
tissue or with the ability of the virus to be transmitted by MC to replicate in T cells (i.e.,
transmission fitness) (Fig. 5d).
Collectively, these data suggest that replication fitness as measured in PBMCs is dif-
ferent from the transmission fitness assessed in the ex vivo human penile explant
model. As discussed below, replicative fitness of HIV-1 in free T cells was unlikely to
predict the efficiency of viruses to penetrate the mucosa and be bound by MC to
trans-infect T cells, which we refer to as transmission fitness.
Transmission fitness is linked to C-type lectin binding affinity. Based on previ-
ous studies, these analyses of Envacute versus Envchronic could not define a specific amino
acid sequence, altered function, or phenotype (12, 13). The only unique feature
appeared to be fewer conserved N-linked sites for some of the Envacute HIV-1 than
Envchronic HIV-1 viruses. Based on these observations, we proposed that the Env glyco-
proteins of acute HIV-1 may have differential binding affinity to C-type lectins. Binding
affinities of Envacute and Envchronic viruses for DC-SIGN and langerin were measured on a
RapID4 acoustic biosensor. In this system, DC-SIGN and langerin were covalently
bound to the surface of a quartz crystal chip. Inactivated Envacute and Envchronic virus
stocks were passed over the chip surface, and kinetic binding parameters were meas-
ured by the variation in resonant frequency. The binding affinity of each virus for DC-
SIGN, langerin, and PHA was then compared to the replication efficiency in both tissue
and MC1PM1 cocultures (Fig. 6). The ability of the viruses to replicate in the tissue was
related to DC-SIGN binding affinity (Fig. 6a). There was also a trend for viruses that
FIG 5 Replication fitness does not predict transmission fitness. Multivirus infection assays in penile tissue were performed, and the average
replication of each Envchronic and each Envacute virus in tissue (a) and in MC1PM1 cocultures (b) was determined by sequencing. (c) Each of
the Envacute viruses was competed against the Envchronic controls in PHA- and IL-2-activated PBMCs to assess the pathogenic fitness (21). The
average pathogenic fitness versus the three Envchronic viruses is shown. (d) The percent replication of Envacute viruses in competitions in
tissue and in MC 1 PM1 cocultures was plotted against the average percent replication in PBMC competitions. ND, not done.
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replicated in tissue to bind with higher affinity to langerin (Fig. 6b). While we observed
a 1,000-fold variation in langerin and DC-SIGN binding affinity, all viruses had similar
binding affinity to PHA (,50-fold variation in dissociation constants) (Fig. 6c). There
were, however, no correlations between binding affinity to these C-type lectins and
transmission fitness, i.e., the ability to bind MC, pass through the tissue, and infect free
CD41 T cells (Fig. 6d to f).
C-type lectins trap HIV-1 replication in the tissue. Previous studies have
described high levels of soluble C-type lectins, like mannose-binding lectins (MBLs), in
mucosal tissue as well as Dectin-1, a C-type lectin on epithelial and endothelial cells.
MBLs are thought to trap pathogens with high-mannose glycans in the mucosa and
prevent translocation (34). Our fluorescent deconvolution microscopy confirms the
presence of MBL in different mucosal tissues (Fig. 7). These analyses serve only to illus-
trate that DC-SIGN and langerin on the myeloid cell lineage in mucosal tissue provide
relatively few binding sites for high-mannose glycans compared to the abundant MBL
in these same tissues. Previous studies have shown that the HIV-1 Env gp120/gp41
found on the virus surface retains N-linked high-mannose glycans and somehow
avoids late Golgi complex (GC) modification responsible for trimming and complex gly-
can content (35, 36).
To evaluate the influence of glycans on the transmission fitness, penile and cervical
explants were pretreated with mannan for 12 h and washed prior to addition of one
acute B4 and one chronic Q0 virus. Saccharomyces cerevisiae mannan, derived from N
linkage, has a conserved mannose(8)–N-acetylglucosamine(2) core structure with
high affinity to all C-type lectins. Replication of virus in both tissue and MC1PM1 was
evaluated by a Gag-specific quantitative PCR (qPCR). Analysis of the total viral copy
FIG 6 Binding profile of Envacute and Envchronic viruses to C-type lectins. Binding to DC-SIGN and langerin was determined using an acoustic biosensor.
Binding affinity (dissociation constant [Kd], in nanomolar units) was determined by binding the lectins of interest to the chip and allowing viruses to flow
over the surface. Average replication in tissue of Envacute (red squares) and Envchronic (green squares) viruses was correlated with the binding affinity to DC-
SIGN (a), langerin (b), and PHA (c). Average transmission fitness in MC1PM1 cocultures of Envacute (red squares) and Envchronic (green squares) viruses was
plotted against the binding affinity to DC-SIGN (d), langerin (e), and PHA (f). PHA was tested as the nonspecific control. Each symbol represents one virus.
Statistical analysis was performed using a Spearman rank correlation analysis.
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number revealed that cervical tissue soaked in mannan prior to virus exposure exhib-
ited 6.7 reduced viral replication compared to untreated tissue (Fig. 8a). In penile tis-
sue, no differences in viral replication were observed between mannan-treated and
untreated tissue (Fig. 8b). In contrast, 3.2 and 3.9 increased HIV-1 copy numbers
were found in MC1PM1 cocultures derived from penile and cervical tissue, respec-
tively, when tissue was treated with mannan (Fig. 8a and b). These findings suggest
that fewer viruses were trapped in tissue treated with mannan and that more viruses
were able to cross the mucosa with MC to infect T cells.
DISCUSSION
In the vast majority of new HIV-1 infections, a stringent transmission bottleneck
leads to the establishment of a systemic infection by a single viral founder (incidence
estimated to be between 76 and 90%) (3). A recent study suggests that this dramatic
decline in the HIV-1 heterogeneity from donor to recipient during transmission may be
related to a genetic bottleneck during the virus inoculation in the recipient as well as
during the translocation of the HIV-1 from the recipient genital mucosa to the blood
FIG 7 Presence of MBL in different mucosal tissue types. (a) Fluorescent deconvolution microscopy images of ectocervix, endocervix, inner foreskin, and
outer foreskin stained for MBL (red) and DAPI (blue). (b) Autofluorescence (green) of the corresponding tissues. Magnification, 40. Bar, 40 mm. Dashed
lines indicate the luminal surface. L, lumen; E, epithelium; S, stroma.
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(6). It remains poorly understood if the bottleneck leading to systemic infection by a
single HIV-1 variant is caused by a stochastic event or if selective factors influence the
efficiency of HIV-1 transmission through the genital mucosa. During transmission, the
HIV-1 genetic bottleneck and any selection (as opposed to stochastic effects) would
likely have multifactorial origins. For example, the genetic bottleneck maybe the result
of a lower activation state of CD4 T cells (37) and/or the fact that in any transmission
event, the majority (.93%) of HIV proviruses are defective (38).
In this study, we evaluated the transmission fitness of HIV-1 harboring subtype B
chronic and acute Env glycoproteins by employing a multivirus competition infection
of primary human penile and cervical tissue. Env chimeric clones were chosen to spe-
cifically determine the role different Env phenotypes play in the mucosal transmission
event. In previous studies, replicative fitness in primary CD41 T cells and macrophages
was dominated by the efficiency of host cell entry and mapped to the env gene (39,
40). By using chimeric clones that share the same backbone, we limited transmission
efficiency to Env derived from HIV-infected patients during acute or chronic infection.
Although Env activity may be dominant or an important trait for transmission, we are
not discounting other HIV-1 proteins/factors that may impact transmission efficiency
(9, 11, 17). Our data show that Envchronic viruses replicate mainly in the mucosal tissue,
while Envacute viruses pass through the tissue with migratory cells and initiate infection
in CD41 T cell lines. Replication of HIV-1 trapped in tissue directly correlated with bind-
ing affinity to C-type lectins. Treating the tissue with a saturating concentration of
mannan resulted in higher efficiency of HIV-1 transmission to T cells.
Based on our tissue model, HIV-1 harboring Env with the highest binding affinity to
C-type lectins showed increased virus replication in the mucosal tissue but was not effi-
ciently transmitted through to CD41 T cells. Our studies suggest that C-type lectins
may “trap” HIV-1 replication in the mucosa and even prevent translocation for systemic
infection. Mucosal biologists/immunologists have known for decades that C-type lec-
tins are highly abundant in foreskin, penile, vaginal, and cervical tissues (41, 42) and
are key innate barriers preventing pathogen translocation. Understanding the role of
C-type lectins in HIV-1 transmission has a long and convoluted history. As early as
1997, Garred et al. (43) described protection from HIV-1 in high-risk cohorts with a spe-
cific promoter polymorphism in mannose-binding lectin loci which led to reduced
expression of mannose-binding lectin (MBL). However, the protective role of C-type
FIG 8 Mannan alters the transmission of HIV-1 across mucosal tissue. (a) Cervical and (b) penile
tissues were incubated in medium alone or medium containing mannan for 12 h before exposure to
a mix of one Envacute and one Envchronic virus. Migratory cells were harvested after 24 h and cocultured
with PM1 T cells. After 10 days in culture, the total HIV-1 copy number in tissue and MC1PM1 cells
with and without mannan was assessed using a gag-specific qPCR. Each assay was performed with
tissue from three donors. The values are means and standard errors of the means.
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lectins in HIV-1 infection was soon eclipsed by studies describing a role of DC-SIGN in
capturing and transmitting HIV-1 (44), which remains a controversial topic (45, 46).
Langerhans cells (LCs) expressing langerin or DCs expressing DC-SIGN are probably the
first immune cells to come into contact with infecting virus in these mucosal tissues.
The proposed role of LCs in HIV-1 transmission was questioned in a study describing
the capture, endocytosis, and degradation of HIV-1 by Birkbeck granules following
binding to langerin on mucosal LCs (47).
Our findings suggest that replicating HIV-1 in the genital mucosa may be trapped
by soluble MBL, shown to have binding specificity for mannose similar to that of the
less abundant DC-SIGN and langerin found on DCs and LCs, respectively (48, 49).
Addition of mannan to genital mucosal tissue would saturate C-type lectin binding
and as a result, reduce trapped HIV-1 replication in the tissue. Surprisingly, addition of
mannan increased HIV-1 transmission through the tissue to infect T cells via tissue mi-
gratory cells. These findings suggest competing roles of C-type lectins in mucosal tis-
sue to prevent HIV-1 translocation for systemic infection versus the role of DC-SIGN
and langerin in enhancing heterosexual HIV-1 transmission. Again, C-type lectins in
mucosal tissue are a primary innate defense mechanism preventing pathogen translo-
cation (50, 51), but this process has not been well defined for HIV-1. There is of course
the added complication that unlike pathogenic microbes that harbor surface glycopro-
teins with high-mannose glycans (e.g., Chlamydia and Candida albicans), HIV-1 glyco-
proteins are subject to the same posttranslational machinery as cellular glycoproteins,
typically resulting in greater glycan diversity and reduced branching. However, Doores
et al. (36) described high-mannose glycans on Env directly from virus particles, whereas
recombinant Env, produced from the same cell types, had more complex glycans, simi-
lar to that observed on cellular glycoproteins. These findings suggest that HIV-1 Env
may escape the medial or trans GC processing in the context of virus replication, possi-
bly through the coexpression of HIV-1 Nef or Vpu accessory proteins.
In summary, we determined that Envacute HIV-1 viruses were more readily transmit-
ted in penile or cervical tissue than Envchronic viruses. Trapped replication in these mu-
cosal tissues was observed with Envchronic viruses and was associated with higher C-
type lectin binding affinity. As described herein and as previously reported, the soluble
MBL is omnipresent in genital mucosal tissues and serves as an innate defense mecha-
nism to prevent microbial translocation. We propose that HIV-1 particles with high
mannose content may be retained in the mucosa and that HIV-1 with Env with reduced
glycan/mannose content may break this trap for systemic infection. These findings are
consistent with our recent observation that a more diverse HIV-1 population infected
the female genital tract while a single HIV-1 variant was found in the blood at early
infection (6). Future studies will focus on determining the actual glycan composition
on the Env glycoprotein of the transmitter/founder HIV-1 clone that is responsible for
new infections and avoids the lectin trap in genital mucosa.
MATERIALS ANDMETHODS
Acute and chronic Env chimeric viruses. Envacute and Envchronic were constructed from 11 acute sub-
type B envelopes obtained from the Center for HIV-1/AIDS Vaccine Immunology (CHAVI) acute infection
studies (3) and three chronic envelopes from patient samples from a Belgian cohort (12, 26). Env chi-
meric viruses were constructed using a yeast-based recombination cloning method as previously
described (52). Briefly, the envelope genes from acute and chronic clones were recombined into
pREC_nfl_NL4-3_Denv/URA3 following transfection into Saccharomyces cerevisiae. Virus was produced
by transfection of the pREC construct with the supplementary vector pCMV_cplt into 293T cells using
the Effectene lipid system (Qiagen, USA) according to the manufacturer’s instructions. All chimeric
viruses were tested for coreceptor usage on U87.CD4 cells expressing either CCR5 or CXCR4 (12, 21) (all
were CCR5 using) and then propagated, and titers were determined on U87.CD4.CCR5 cells using the
50% tissue culture infective dose (TCID50) assay. Subsequent experiments on transmission fitness
involved tissue explants that harbor a variety of lymphoid and myeloid cells that are susceptible to HIV-
1 infection. Previous studies have shown that these HIV-1 stocks differ by 1 log in absolute TCID50 titers
derived from PBMCs and primary T cells from different donors and from T cell lines, but the relative dif-
ference in titers remained similar. The acute viruses are termed B1, B2, B3, B4, B7, B8, B9, B14, B17, B19,
and B20, and the three chronic control Env chimeric viruses are named I10, K44, and Q0 (12). Neighbor-
joining phylogenetic tree analysis was performed to compare sequences of the original acute HIV-1 env
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genes derived from single genome amplification (SGA) to those of the acute chimeric env viruses and to
highlight the diversity within the chronic env chimeric viruses. Neighbor-joining trees were constructed
with SEAVIEW 4 and visualized with FigTree 1.4.2.
Ethics statement. Human penile and cervical tissue was collected with written consent according to
local research committee (LRC) guidelines. All tissues were obtained under protocols approved by the
Imperial College NHS Trust Tissue Bank and the National Research Ethics Committee in accordance with
the Human Tissue Act 2004.
HIV-1 transmission fitness assay in human explant tissue. For this study, for lack of a better term,
we describe ex vivo transmission fitness as the ability of the virus to enter the tissue, to be carried by
and/or infect migratory cells, and then to be transferred to free T cells.
Deidentified penile tissue was obtained from men undergoing gender reassignment surgery at
Charing Cross Hospital, London, United Kingdom. Deidentified endo- and ectocervical tissue was col-
lected from women undergoing therapeutic hysterectomy at St. Mary’s Hospital, London, United
Kingdom. Penile and cervical tissue, including both epithelium and stroma, were cut into 3-mm3
explants, and four tissue pieces were added per well in a 24-well tissue culture plate. Multivirus competi-
tions were set up such that each of the 11 Envacute viruses was competed against the other and always
against the three chronic viruses. Tissue blocks were then exposed to a mixture of four or five Envacute
viruses (B1, B2, B3, B4, B7, B8, B9, B14, B17, B19, and B20) and the same three Envchronic viruses (I10, K44,
and Q0) at 150 IU per virus for 3 h at 37°C. The tissue was then washed three times to remove free virus
and cultured in complete RPMI 1640 medium (Sigma, United Kingdom) at 37°C.
Migratory cells (MC) migrating out of the tissue were harvested at 24 h and washed 3 times with
phosphate-buffered saline (PBS) by centrifugation for 3 min at 350 g. MC were then cocultured with
105 PM1 CD41 T cells in complete RPMI for 10 days at 37°C. The explant tissues were washed 3 times
with PBS, resuspended in complete RPMI, and cultured for 10 days at 37°C. For MC–T cell cocultures and
tissue cultures, half of the supernatant was harvested for analysis and replaced with fresh medium every
3 days. On day 10, the tissue was washed 3 times with PBS and lysed with 300ml of 1% Triton X-100 sup-
plemented with 1mg/ml proteinase K overnight at 56°C. Cells from MC1PM1 T cell cocultures were
washed 3 times with PBS and lysed with 300ml of 1% Triton X-100. Each multivirus competition was per-
formed in tissues from two donors in triplicate. DNA was extracted from lysates using the PureLink Pro
96 genomic DNA kit (Invitrogen, USA) according to the manufacturer’s instructions. The extraction pro-
cedure was performed using the epMotion 5075 automated liquid handling and pipetting system
(Eppendorf, USA).
HIV-1 transmission fitness assay in mannan-treated human explant tissue. Transmission fitness
assays were performed as described above with penile and cervical explant tissues incubated in medium
alone or medium containing 1mg/ml mannan (Sigma, Canada) for 12 h before infection with a mixture
of one Envacute (B4) and one Envchronic (Q0) virus. Each condition was tested in tissues from three donors
in triplicate. The total HIV-1 copy numbers in tissue and MC1PM1 cocultures were assessed using a
Gag-specific qPCR.
Flow cytometry. For phenotypic analysis of DCs migrating from penile and cervical tissue, a multi-
colored flow cytometry antibody cocktail was used, consisting of CD14 Qdot605 (TüK4) (Invitrogen),
CD11c AF700 (B-ly6), CD123 PECy5 (9F5), CD209 V450 (DCN46), Lin-1 fluorescein isothiocyanate (FITC),
CD1c PECy7 (L161) (BioLegend, United Kingdom), HLA-DR allophycocyanin (APC) H7 (G46-6), CD207 APC
(10E2) (BioLegend, United Kingdom), and CD83 phycoerythrin (PE) (HB15e). Unless otherwise specified,
all antibodies were obtained from BD Biosciences, United Kingdom. Dead cells were excluded from anal-
ysis through staining with Aqua viability dye (Invitrogen, United Kingdom). Samples were acquired using
an LSRIIFortessa fluorescence-activated cell sorter (FACS; BD Biosciences, United Kingdom) and analyzed
using FlowJo (Tree Star, USA). Compensation matrices were created on FlowJo using single stained anti-
mouse Ig(κ) negative-control compensation beads (BD Biosciences, United Kingdom).
PCR and NGS analysis of multivirus infections. HIV-1 DNA was PCR amplified from cellular DNA
extracts. It is important to stress that the HIV-1 DNA and not the viral RNA was PCR amplified from cellu-
lar DNA extracts to ensure some level of virus infection rather than just residual inoculating virus after
extensive washing. At a minimum, this viral DNA results from initial reverse transcription, but it likely
represents a spreading HIV-1 infection due to the increasing viral DNA load over the 10-day incubation.
PCR amplification of the C2-V3 envelope region and 454 sequencing were performed as previously
described (6). The C2-V3 region of the envelope gene was amplified by an external-nested PCR amplifi-
cation. Primers used for the external PCR were forward ENVB (59-AGAAAGAGCAGAAGACAGTG
GCAATGA-39) (HXB2 positions 6202 to 6228) and reverse ED14 (59-TCTTGCCTGGAGCTGCTTGATGCC
CCAGAC-39) (HXB2 positions 7932 to 7961), and those for nested PCR were forward E80 (59-CCAAT
TCCCATACATTATTGTG-39) (HXB2 positions 6858 to 6879) and reverse E125 (59-CAATTTCTGGGTCCCCTC
CTGAGG-39) (HXB2 positions 7315 to 7338) (6). PCR mixtures contained a 0.2 mM concentration of each
primer, 1.5mM MgCl2, 1 Platinum Taq PCR buffer, 0.2mM deoxynucleotide triphosphates (dNTPs), and
2 U Platinum Taq DNA polymerase. PCR cycle conditions were 95°C for 2min, followed by 35 cycles of
95°C for 30 s, 55°C for 30 s, and 72°C for 2min (external) or 45 s (nested), and a final extension of 72°C
for 10min.
To prepare the amplicon library for 454 sequencing, fusion primers including the Roche 454
Titanium key sequence, a multiplex identifier (MID) sequence for forward and reverse primers followed
by the template-specific sequences forward E110 (59-CTGTTAAATGGCAGTCTAGCAGAA-39) (HXB2 posi-
tions 7002 to 7025) and reverse E125 (59-CAATTTCTGGGTCCCCTCCTGAGG-39) (HXB2 positions 7315 to
7338) were used. PCR cycle conditions were 95°C for 2min, followed by 35 cycles of 95°C for 30s, 55°C
for 30 s, and 72°C for 45 s, and a final extension of 72°C for 10min. PCR products were run on a 1%
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agarose gel to verify the product size of 406 bp and purified using the Agencourt AMPure XP bead sys-
tem with a bead-to-DNA ratio of 0.7:1 according to the Roche manual. Sample libraries were quantified
using the Quant-iT PicoGreen double-stranded-DNA assay kit (Invitrogen, Canada), diluted, and pooled
at 106 molecules/ml for pyrosequencing. Emulsion PCR (emPCR) was performed with a ratio of 0.5 mole-
cules of sample library per bead. Enriched beads (5 105) were then loaded onto titanium picotiter
plates according to the Roche 454 instructions. The sequencing run was performed on the Roche 454
GS Junior sequencer as previously described (6). Next-generation sequencing (NGS) analyses was
employed as a sophisticated and sensitive counting tool, and the higher error rate seen with Roche 454
has no bearing on these results.
Sequence data analysis. A custom analysis pipeline (a revision of Segminator II [53] and SeekDeep
[27]) was used to quantify each virus within a competition. First, raw sequence data were extracted by
the MID tag. Next-generation sequences were analyzed for quality and length, and then the relative
amount of each virus was determined via maximum-likelihood phylogenetic tree alignments,
SeekDeep alignments, groups, and count sequences within a cluster aligning to each of the input viral
sequences.
Lectin binding assay. The relative binding affinity of Envacute and Envchronic HIV-1 to C-type lectins
was assessed using an Akubio RapID4 acoustic biosensor (TTP Labtech). DC-SIGN and langerin were pre-
pared in sodium acetate buffer and covalently bound to a quartz crystal using an ethyl carbodiimide
hydrochloride (EDC) and N-hydroxysulfosuccinimide (NHS) amine linkage. Free ester groups were neu-
tralized by ethanolamine blocking. Viral stocks normalized for p24 concentration were allowed to flow
over the immobilized lectins for 3 min at a flow rate of 25 ml min21, followed by a 5-min dissociation
step. The quartz crystal surface was regenerated using a 100mM glycine buffer (pH 2.5) containing
0.05% Tween 20 for 3min. PHA was used as a nonspecific lectin control.
Immunofluorescence and imaging. Frozen tissue sections (12mm) were fixed in 3.7% formalde-
hyde in PIPES [piperazine-N,N9-bis(2-ethanesulfonic acid)] buffer for 5 to 10 min, followed by washing in
cold PBS. Samples were blocked with normal donkey serum for 10 min and washed again. For mannan-
binding lectin (MBL) identification, samples were stained (1:100; clone 3B6; Abcam) for 1 h at 37°C and
then washed with cold PBS. Next, a Cy5-labeled donkey anti-mouse immunoglobulin secondary anti-
body (Jackson ImmunoResearch, USA) was added for ;20 to 30 min at room temperature. Samples
were washed, and Hoechst DAPI (49,6-diamidino-2-phenylindole; Invitrogen, USA) was applied for 10
min to stain nuclei before a final wash with PBS. Mounting medium (DakoCytomation) and coverslips
were applied to sections, sealed with clear nail polish, and stored at 4°C. Images were obtained by
deconvolution microscopy on a DeltaVision RT system collected on a digital camera (CoolSNAP HQ;
Photometrics) using a 40 oil objective. Panel images at a magnification of 40 were acquired to
include the epithelium and the underlying connective tissue in all ex vivo human samples. After image
acquisition, SoftWoRx analysis software (Applied Precision) was used to stitch and quickly project up to
30 z-stacks per panel set.
Quantitative PCR. Samples were run using the QuantStudio5 real-time PCR system (Applied
Biosystems, Canada) using gag-specific primers as previously described (54). First, an external HIV-1 gag-
specific PCR was performed in a 50-ml reaction mixture containing 1 PCR buffer, 1mM MgCl2, 0.2mM
dNTPs, 2 U of Platinum Taq DNA polymerase, and 0.2mM concentrations of forward primer gag-cons1
(59-GAGAGAGATGGGTGCGAGAGCG-39) (HXB2 positions 783 to 804) and reverse primer UNIV-GA4 (59-
TTGCCAAAGAGTGACCTGAGGGAA-39) (HXB2 positions 2250 to 2273). PCR was performed using the
Simpliamp thermocycler (Applied Biosystems, Canada) under the following reaction conditions: 95°C for
2min, followed by 35 cycles of 95°C for 30 s, 55°C for 30 s, and 72°C for 1min 50 s, and a final extension
of 72°C for 10min.
Following PCR, 20ml PCR product was added to a qPCR mixture which included 0.5mM concentra-
tions of forward primer gSCA F (59-CATGTTTTCAGCATTATCAGAAGGA-39) (HXB2 positions 1299 to 1323)
and reverse primer gSCA R (59-TGCTTGATGTCCCCCCACT-39) (HXB2 positions 1359 to 1377), 0.2mM gSCA
probe (59-FAM [6-carboxyfluorescein]-TACTGGGACAGCTACAACCATCCCTT-BHQ [black hole quencher]-
39) (HXB2 positions 968 to 993), and TaqMan Fast advanced master mix. Samples were run under the fol-
lowing reaction conditions: 60°C for 2min, 95°C for 20 s, and 40 cycles of 95°C for 1 s and 60°C for 43 s.
All samples were run in duplicate. Samples were considered negative when cycle threshold (CT) values
were above 35.
Statistical analysis. Statistical analysis was performed on GraphPad Prism 6, using the Holm-Šidák
test to compare the average replication of Envchronic with Envacute in each competition, a two-tailed
Mann-Whitney test to compare the total average replication of Envchronic and Envacute in tissue (with and
without mannan) with that in MC1PM1 cocultures, and a Spearman rank correlation analysis for com-
parison of lectin binding affinity and replication in tissue or MC1PM1 cocultures. P values of ,0.05 were
considered significant.
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